Journal of Clinical Microbiology, April 1999, p. 1178-1181, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Laboratoire de Santé Publique du
Québec,
Received 20 July 1998/Returned for modification 16 October
1998/Accepted 11 December 1998
In a context of worldwide emergence of resistance among
Streptococcus pneumoniae strains, early detection of
strains with decreased susceptibility to
-lactam antibiotics is
important for clinicians. If the 1-µg oxacillin disk diffusion test
is used as described by the National Committee for Clinical Laboratory Standards, no interpretation is available for strains showing zone
sizes of
19 mm, and there is presently no disk diffusion test
available for screening cephalosporin resistance. The zones obtained by
the diffusion method by using the 1-µg oxacillin disk were compared
with penicillin MICs for 1,116 clinical strains and with ceftriaxone
MICs for 695 of these strains. Among the 342 strains with growth up to
the 1-µg oxacillin disk margin, none were susceptible (MIC,
0.06
µg/ml), 62 had intermediate resistance (MIC, 0.12 to 1.0 µg/ml),
and 280 were resistant (MIC,
2.0 µg/ml) to penicillin. For
ceftriaxone, among 98 strains with no zone of inhibition in response to
oxacillin, 68 had intermediate resistance (MIC, 1.0 µg/ml), and 22 were resistant (MIC,
2.0 µg/ml). To optimize the use of the disk
diffusion method, we propose that the absence of a zone of inhibition
around the 1-µg oxacillin disk be regarded as an indicator of
nonsusceptibility to penicillin and ceftriaxone and recommend that such
strains be reported as nonsusceptible to these antimicrobial agents,
pending the results of a MIC quantitation method.
*
Corresponding author. Mailing address: Laboratoire de
Santé Publique du Québec, 20045 Chemin Sainte-Marie,
Sainte-Anne-de-Bellevue (Québec) Canada H9X 3R5. Phone: (514)
457-2070. Fax: (514) 457-6346. E-mail: ljette{at}lspq.org.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|